New pill aims to tackle obesity and diabetes by calming inflammation
Disease control
Completed
This study tests an experimental drug called NT-0796 in 176 obese adults, some with type 2 diabetes. Participants take the drug or a placebo alongside a reduced-calorie diet and increased physical activity for 6 months. The goal is to see if the drug helps with weight loss and re…
Phase: PHASE2 • Sponsor: NodThera Limited • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC